View Future GrowthThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsAmesite 과거 순이익 실적과거 기준 점검 0/6Amesite 의 수입은 연평균 -20.6%의 비율로 감소해 온 반면, Consumer Services 산업은 연평균 10.7%의 비율로 증가했습니다. 매출은 연평균 60.9%의 비율로 증가해 왔습니다.핵심 정보-20.55%순이익 성장률-0.70%주당순이익(EPS) 성장률Consumer Services 산업 성장률10.54%매출 성장률60.86%자기자본이익률-76.87%순이익률-608.01%최근 순이익 업데이트31 Mar 2023최근 과거 실적 업데이트Reported Earnings • Nov 16First quarter 2023 earnings released: US$0.058 loss per share (vs US$0.11 loss in 1Q 2022)First quarter 2023 results: US$0.058 loss per share (improved from US$0.11 loss in 1Q 2022). Revenue: US$280.3k (up 99% from 1Q 2022). Net loss: US$1.58m (loss narrowed 34% from 1Q 2022). Revenue is forecast to grow 94% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Consumer Services industry in Europe.Reported Earnings • Nov 12First quarter 2023 earnings released: US$0.058 loss per share (vs US$0.11 loss in 1Q 2022)First quarter 2023 results: US$0.058 loss per share (improved from US$0.11 loss in 1Q 2022). Revenue: US$280.3k (up 99% from 1Q 2022). Net loss: US$1.58m (loss narrowed 34% from 1Q 2022). Revenue is forecast to grow 94% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Consumer Services industry in Europe.Reported Earnings • Sep 29Full year 2022 earnings released: US$0.39 loss per share (vs US$0.59 loss in FY 2021)Full year 2022 results: US$0.39 loss per share (improved from US$0.59 loss in FY 2021). Revenue: US$697.0k (up 3.3% from FY 2021). Net loss: US$9.06m (loss narrowed 22% from FY 2021). Revenue is forecast to grow 85% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Consumer Services industry in Europe.Reported Earnings • May 14Third quarter 2022 earnings released: US$0.093 loss per share (vs US$0.11 loss in 3Q 2021)Third quarter 2022 results: US$0.093 loss per share (up from US$0.11 loss in 3Q 2021). Net loss: US$2.22m (loss narrowed 4.6% from 3Q 2021).Reported Earnings • Nov 18First quarter 2022 earnings released: US$0.11 loss per share (vs US$0.31 loss in 1Q 2021)First quarter 2022 results: Net loss: US$2.38m (loss narrowed 53% from 1Q 2021).Reported Earnings • Sep 11Full year 2021 earnings released: US$0.59 loss per shareFull year 2021 results: Net loss: US$11.6m (loss widened 178% from FY 2020).모든 업데이트 보기Recent updates공시 • Oct 30+ 1 more updateAmesite Inc. Announces Upcoming Product PlansAmesite announced the planned launch of what it believes is the industry’s first AI-powered EMR platform for post-acute care, aiming to deliver operational efficiency for the fastest-growing healthcare segments.공시 • Jul 14Amesite Launches Census-Based Enterprise Tier for NurseMagic™ to Drive Revenue Growth and Meet Enterprise Demand, Significantly Expanding Total Addressable MarketAmesite Inc. announced the launch of the new NurseMagic™ Enterprise Tier, built to meet the most urgent needs of mid- and large-scale post-acute healthcare providers. Developed in direct response to customer demand, NurseMagic™ Enterprise integrates advanced, AI-powered capabilities into existing workflows — seamlessly and compliantly. By aligning pricing with patient census, Amesite believes this offering significantly increases its addressable market and supports long-term revenue growth. NurseMagic™ Enterprise includes:Seamless EMR integration. NurseMagic™ Enterprise enables bi-directional data transfer and connectivity with electronic medical records (EMRs), allowing documentation created in NurseMagic™ Enterprise to populate directly into clinical systems. This integration is designed to fit seamlessly into existing workflows — preserving continuity for staff while delivering unparalleled documentation efficiency. Automated interdisciplinary team (IDT) reporting. NurseMagic™ now generates formatted IDT reports automatically, streamlining one of the most time-intensive compliance processes for home health and hospice agencies. This feature is built to operate within current team structures — saving time without requiring teams to change how they work. Custom-formatted documentation for compliance and billing. NurseMagic™ Enterprise supports customer-specific templates for documentation required by payers, regulators, and internal teams. This assures that providers can continue to use their own established forms — now generated faster and with greater consistency with NurseMagic™’s powerful, proprietary AI tools. Census-based pricing that scales with care delivery. By tying pricing to patient census rather than staff count, NurseMagic™ enables organizations to deploy across full care teams with clarity and control. This model supports growth without operational disruption — and positions Amesite to capture revenue as census expands. With the launch of NurseMagic™ Enterprise, Amesite will discontinue new sales of its entry-level B2B Teams plan. Going forward, B2B customers will choose between Teams Plus+, intended for organizations with smaller patient censuses, and the new NurseMagic™ Enterprise Tier, which supports larger-scale deployment and full-agency efficiency. Existing Teams customers will continue to be supported. Amesite believes that consolidating around these two enhanced tiers enables the Company to capture more value from each organization served and positions it to drive stronger recurring revenue growth.공시 • Jun 26Amesite Inc.'s HIPAA Compliant NurseMagic App Now Operates in 16 Languages - Expanding Access to AI-Powered Charting for Nearly 1 Million U.S. NursesAmesite Inc. announced that its app, NurseMagic, now supports charting in 16 languages. This major enhancement is designed to address a key barrier to success for nearly 1 million nurses in the U.S. who speak English as a second language (ESL) -- accounting for 19.2% of the nursing workforce -- and to chart more efficiently and with greater confidence. This multilingual capability positions Amesite to meet immediate market needs. Markets now able to leverage the platform include: ESL nurses in the United States: Nearly 20% of U.S. nurses have English as a Second Language (ESL); International healthcare systems treating U.S. patients: There are over 6.5 Million nurses in the top 10 medical tourist destinations for U.S. patients alone; Private clinics in multilingual regions: The private sector provides nearly 40% of all healthcare in PAHO, AFRO, and WPRO regions, 57% in SEARO, and 62% in EMRO.공시 • May 06Amesite Announces Successful Launch of New, Higher-Priced Tier of Service in Response to B2B DemandAmesite Inc. announced the successful launch of a higher-priced enterprise tier of service of its app, NurseMagicTM. Amesite reports that businesses demanded more capacity after incorporating NurseMagicTM fully into their workflows - and have reported a strong willingness-to-pay for the increased usage at a higher price point. Amesite also reports that customers also wanted access to advanced analytics, now accessible 24/7 with the Teams Plus+ tier of service. Amesite reports a marked increase in enterprise clients deploying NurseMagic™ across entire clinical and non-clinical teams, from nurses and CNAs to chaplains, aides, and coordinators. As these customers scale usage, they gain access to real-time insights, productivity metrics, and tools that reduce costs and improve retention with the new pricing tier. This new tier follows announcements regarding meeting HIPAA regulation, delivering to the growing hospice segment and delivery of solutions for non-clinical workers in addition to clinical staff.공시 • Apr 23Amesite Announces NurseMagic Meets HIPAA Requirements for Individuals Users, in Addition to EnterprisesAmesite Inc. announced NurseMagic now meets HIPAA requirements for all users. This extension ensures that all usage—individual or enterprise—meets regulatory standards for handling sensitive healthcare information. Amesite announced that it met HIPAA requirements for enterprises late last year, and subsequently reported increased sales in B2B. To meet HIPAA requirements, care providers are required to execute a Business Associate Agreement (BAA) with their software vendors. NurseMagic now provides a BAA for all users, whether licenses are purchased by enterprises or by individuals. Any provider can confidently enter patient details or other personally identifiable health information (PHI) into NurseMagic™’s safe, secure environment. Users can copy and paste documentation produced with NurseMagic into any electronic medical record (EMR) system, enabling them to take advantage of NurseMagic™’s AI capabilities, no matter their current software infrastructure.공시 • Mar 11Amesite Announces Successful Soft Rollout of NurseMagic Caregiver Solution, Expanding Its Addressable Market for Enterprise by 50%Amesite Inc. announced the early adoption of its non-clinical caregiver tool in NurseMagic. The Caregiver NurseMagic Solution directly supports non-clinical workers in their day-to-day jobs, reducing the need for intensive intervention by management, and improving documentation, communication and patient care. Amesite sales are focused on home health care and skilled nursing. Agencies and corporations in these segments employ both clinical and non-clinical staff. Broadly, there are almost 3 million home health care and skilled nursing staff in the U.S., of which over 1.5 million are non-clinical healthcare support workers. By expanding NurseMagic solutions to meet the needs of non-clinical workers, Amesite estimates that it has expanded its addressable market for enterprise sales alone by around 50%. Amesite reports that an increasing number of customers have adopted NurseMagic for their entire teams, which include non-clinical staff such as CNAs, chaplains, social workers and nurse aides. Over the last three months, Amesite reported that its contracts with hospice providers have grown by over 3,000%, and contract sizes have increased by nearly 1,000%. This comes on the heels of Amesite's recent rollout of its automated purchase process that enables contract expansion with a few clicks, substantially shortening its sales cycle as it reaches the over 50,000 businesses in its target segments.공시 • Jan 09Amesite Inc. has completed a Follow-on Equity Offering in the amount of $4.865001 million.Amesite Inc. has completed a Follow-on Equity Offering in the amount of $4.865001 million. Security Name: Common Stock Security Type: Common Stock Securities Offered: 1,201,667 Price\Range: $3 Discount Per Security: $0.24 Security Name: Common Stock Security Type: Common Stock Securities Offered: 420,000 Price\Range: $3 Discount Per Security: $0.12공시 • Jan 07Amesite Inc. has filed a Follow-on Equity Offering.Amesite Inc. has filed a Follow-on Equity Offering. Security Name: Common Stock Security Type: Common Stock Security Name: Pre-Funded Warrants Security Type: Equity Warrant공시 • Dec 04Amesite Receives a Deficiency Letter from the Listing Qualifications Department of the Nasdaq Stock MarketOn November 26, 2024, Amesite Inc. received a deficiency letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC notifying the Company that it is not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires the Company to maintain a minimum of $2,500,000 in stockholders’ equity for continued listing on the Nasdaq Capital Market, nor is it in compliance with either of the alternative listing standards, either a market value of listed securities of at least $35 million or net income of $500,000 from continuing operations in the most recently completed fiscal year, or in two of the three most recently completed fiscal years. Pursuant to the Nasdaq Letter, the Company has 45 calendar days from the date of the Nasdaq Letter to submit a plan to regain compliance and the Company intends to submit such a plan during this period. If it accepts the plan, Nasdaq can grant an extension of up to 180 calendar days from the date of the Nasdaq Letter to evidence compliance. In the event the plan is not accepted by Nasdaq, or in the event the plan is accepted and the 180-day extension period granted but the Company fails to regain compliance within such plan period, the Company would have the right to a hearing before an independent panel. The hearing request would stay any suspension or delisting action pending the conclusion of the hearing process and the expiration of any additional extension period granted by the panel following the hearing. The Company intends to take all reasonable measures available to regain compliance under the Nasdaq Listing Rules and remain listed on Nasdaq. However, there can be no assurance that Nasdaq will grant the Company’s request for an extension or that the Company will ultimately regain compliance with all applicable requirements for continued listing. Neither the Nasdaq Letter nor the Company’s noncompliance have an immediate effect on the listing or trading of the Company’s common shares, which will continue to trade on the Nasdaq Capital Market under the symbol “AMST”.공시 • Nov 28Amesite Inc., Annual General Meeting, Jan 21, 2025Amesite Inc., Annual General Meeting, Jan 21, 2025.공시 • Jul 16Amesite Inc. Launches PREACTO App in Beta to Power Safety and Security At Home, Work, School and in Public VenuesAmesite Inc. announced that the beta registration is now available for PREACTO, an innovative and proprietary app designed for personal safety and security. The new web app uses AI to provide helpful and easy-to-use tools for people who want to make their safety and security a priority, allowing them to proactively assess threats, plan safe routes and activities, update law enforcement, notify their circle of family and friends, and more. The app will also offer Active Shooter Preparedness content developed together with world renowned expert Chris Grollnek, #ActiveShooterexpert, and founder of the Active Shooter Prevention Project. Amesite and ASPP announced their collaboration in March to create the app. The app targets serving Grollnek’s expansive audience and customer base, including Fortune 100 and 500 companies, small to large corporations and businesses, the entire government sector, public entities, and other organizations. This broad client base reflects the universal need for effective crisis response training across all sectors of society. Americans are increasingly focused on reducing crime, with 58% of U.S. adults stating that crime reduction should be a top priority of the President and Congress, up from 47% in 2021. 40% of Americans, the highest percentage in three decades, report that they would be afraid to walk alone at night within a mile of their home. Fully 66% of adults reported that they avoided common activities because of fear of crime, including attending public events, visiting central areas of cities, taking walks, exercising or visiting local parks. PREACTO’s toolkit is designed to make these activities safer and more secure. RescueCall instantly notifies loved ones and emergency services, ensuring swift assistance. CrimeMap provides real-time updates on local crime activities, helping users avoid dangerous areas. The app’s SafeZone feature offers risk assessments based on a user’s current location, while SafePath provides the safest route to any destination. Additionally, WeaponSight uses phone cameras to identify potential threats, and IncidentReporter enables fast documentation and reporting of threatening behavior to law enforcement or workplace authorities.공시 • Jul 12Amesite Inc. Announces AI-Powered Document Storage and Study Tools on NurseMagic™? App to Power Instantaneous Training for Nurses and Nursing StudentsAmesite Inc. announced that its NurseMagicTM app now supports nursing students and professionals ranging from CNAs and LPNs to APRN-CNPs and NPs. The functionality supports any type of documentation, training and learning. NurseMagicTM has experienced rapid adoption by nurses following its release to the general public, targeting over 5.2 million nurses. Its proprietary technology has demonstrated 93% accuracy when tested on prep questions for the NCLEX, the exam that must be passed by nurses in the U.S. and Canada in order to be licensed. Users can upload pdf, video and audio files to instantly create transcripts, summaries and even quizzes and flashcards based on the material. Uploadable content spans recorded and written lecture materials, training materials and professional guidelines along with informal materials created via mentorship. With the new functionality, nurses can access instantaneous training. Additionally, users can share materials easily on the app and create their own file structures, enabling scaling of distribution of informal and formal learning, training and other professional materials.공시 • Apr 24Amesite Inc. Launches Revolutionary NurseMagic App in Beta to Empower 5.2 Million Nurses with AI ToolsAmesite Inc. announced the beta release of NurseMagic™, an innovative and proprietary app designed for nurses. This new web app uses AI to provide helpful and easy-to-use tools for over 5.2 million nurses, making their daily tasks easier and more efficient. Additionally, with its status as a Joint Provider with PACE, also offers convenient, accredited continuing education (CE) programs to nurses on the app, enabling them to meet requirements for licensure. NurseMagic™ features include: MedDecode: Quickly translates medical terms into simple language. Professional Email Generator: Creates practical work emails quickly. CareTalk: Assists nurses in talking to patients effectively and with compassion. Wellness Break: Coaches nurses on taking effective breaks during the day. MedExplainer: Enables nurses to explain medical practices to patients. Image-to-Text: Converts images to text for easy reading and communication.MedUverse: Offers key information about medications. NurseTea: Collects instant feedback through surveys that are shared with the community.공시 • Jan 24Amesite Inc. Launches Active Shooter Preparedness Training with Expert Chris GrollnekAmesite Inc. announced the launch of its Active Shooter Preparedness Training program. This essential training is developed in collaboration with renowned active shooter prevention expert Chris Grollnek, M.S., Founder and Managing Principal of the Active Shooter Prevention Project, LLC (ASPP). Amesite's partnerships with regional and community colleges aim to deploy these learnings to a wider audience and enhance safety protocols across the country.공시 • Jan 05Amesite Inc. Partners with Central Michigan University to Launch A Pioneering Asynchronous Implicit Bias Course for Healthcare ProfessionalsAmesite Inc. announced the launch of a new asynchronous Implicit Bias course tailored for healthcare professionals. This course is the result of a partnership between Amesite and CMU's College of Medicine, along with key insights from Dr. Sheri Pickover, a distinguished professor and program director in CMU's Counseling, Educational Leadership & Higher Education department. Delivered through CMU's Online Professional Education portal powered by Amesite's cutting-edge learning platform, this course is meticulously designed to deepen the understanding of implicit bias in healthcare settings. It goes beyond raising awareness, enabling participants to apply these vital insights in reforming healthcare policies and practices. Key Course Highlights: LARA Requirements: The asynchronous course meets the LARA two-hour training requirement as established by the State of Michigan. Medical Professionals: Earn 2.0 American Medical Association's Physician's Recognition Award Category one credits upon successful completion. Educators: Fulfill 1.0 Student Continuing Education Clock Hour (SCECH) requirements mandated by the Michigan Department of Education (MDE). This course will help foster inclusivity and reduce implicit bias within healthcare. The asynchronous course equips healthcare professionals, educators and advocates with the knowledge and tools necessary to make a tangible difference in their respective fields.공시 • Dec 09Amesite Inc., Annual General Meeting, Jan 18, 2024Amesite Inc., Annual General Meeting, Jan 18, 2024, at 08:45 US Eastern Standard Time. Agenda: To consider the election of three Class III Directors to hold office until successors are duly elected and qualified or until the 2026 Annual Meeting of Stockholders; to consider the ratification of the appointment of Turner, Stone & Company, L.L.P. as the Company's independent registered public accounting firm for the fiscal year ending June 30, 2024; and to transact such other matters as may properly come before the Annual Meeting and any adjournment or postponement thereof.공시 • Sep 28Amesite Inc. announced delayed annual 10-K filingOn 09/27/2023, Amesite Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.공시 • Jun 29Amesite Announces V6.3, with Streamlined, AI-First Infrastructure to Enable Customization and Scale for Its Enterprise CustomersAmesite Inc. announces that V6.3 will be available to its Customers on July 10, 2023. By implementing Azure's cloud solutions, Amesite has enhanced its platform’s efficiency and ensured secure authentication with Azure AD B2C. The incorporation of Azure's latest database technology enables Amesite to deliver services faster and improve user experiences. The centralization of Amesite’s innovation deployments allows rapid access to new features such as games and other AI offerings. This significant update reaffirms Amesite’s dedication to addressing customers' ever-evolving needs and delivering an unrivaled user experience. Amesite’s V6.3 includes upgraded cybersecurity with centralized security measures and updates to fortify protection against cyber threats. Enhanced visibility achieved through centralized monitoring allows proactive identification of vulnerabilities, paired with the ability to rapidly deploy security patches across all tenants. In addition, Amesite’s scalable customer support facilitates frictionless resource allocation to manage Customer inquiries and onboarding efficiently.공시 • Feb 15+ 1 more updateAmesite Inc. announced delayed 10-Q filingOn 02/14/2023, Amesite Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Dec 17Amesite Inc. Announces CFO ChangesOn December 9, 2022, the board of directors of Amesite Inc. authorized and approved the appointment of Sherlyn W. Farrell, age 60, as Chief Financial Officer of the Company effective December 15, 2022. In connection with Ms. Farrell’s appointment, the Board determined not to renew the engagement of Mark Corrao, who previously served as the Company’s Chief Financial Officer since December 15, 2021 for a term of one year in accordance with the CFO Agreement between the Company and Mr. Corrao. Ms. Farrell has extensive experience in accounting, financial analysis, and risk management. Since 2005, Ms. Farrell has served as President of Seven Kites Strategic Consulting Inc. (“Seven Kites”), where she focused on strategic planning, CFO oversight, financial reporting and analysis. Prior to Seven Kites, Ms. Farrell served as Chief Executive Officer of RGL Forensics from 2000 through 2005. RGL Forensics was a leading financial investigations company that specialized in the insurance, legal and corporate markets that was acquired by Baker Tilly in 2018. From 1999 – 2000, Ms. Farrell served as a Partner /Senior Consultant at RiskCap where she focused on the alternative risk finance arena developing and managing specialty insurance programs, including medical malpractice, workers compensation, general liability and warranty programs. Prior to RiskCap, Ms. Farrell was an audit manager at KPMG from 1984 – 1989.Reported Earnings • Nov 16First quarter 2023 earnings released: US$0.058 loss per share (vs US$0.11 loss in 1Q 2022)First quarter 2023 results: US$0.058 loss per share (improved from US$0.11 loss in 1Q 2022). Revenue: US$280.3k (up 99% from 1Q 2022). Net loss: US$1.58m (loss narrowed 34% from 1Q 2022). Revenue is forecast to grow 94% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Consumer Services industry in Europe.Reported Earnings • Nov 12First quarter 2023 earnings released: US$0.058 loss per share (vs US$0.11 loss in 1Q 2022)First quarter 2023 results: US$0.058 loss per share (improved from US$0.11 loss in 1Q 2022). Revenue: US$280.3k (up 99% from 1Q 2022). Net loss: US$1.58m (loss narrowed 34% from 1Q 2022). Revenue is forecast to grow 94% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Consumer Services industry in Europe.공시 • Oct 29Amesite Inc., Annual General Meeting, Dec 15, 2022Amesite Inc., Annual General Meeting, Dec 15, 2022, at 08:45 US Eastern Standard Time. Agenda: To consider Election of two Class II Directors to hold office until successors are duly elected and qualified or until the 2025 Annual Meeting of Stockholders; to Ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending June 30, 2023; and to consider other business matters.Reported Earnings • Sep 29Full year 2022 earnings released: US$0.39 loss per share (vs US$0.59 loss in FY 2021)Full year 2022 results: US$0.39 loss per share (improved from US$0.59 loss in FY 2021). Revenue: US$697.0k (up 3.3% from FY 2021). Net loss: US$9.06m (loss narrowed 22% from FY 2021). Revenue is forecast to grow 85% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Consumer Services industry in Europe.공시 • Jun 23Amesite Inc. Announces Expansion of Its Capabilities to Serve Larger Entities, with the Launch of Version 5.0 of Its AI-Driven Online Learning PlatformAmesite Inc. announced the expansion of its capabilities to serve larger entities, with the launch of Version 5.0 of its AI-driven online learning platform. Version 5.0 of the Amesite Learning Community EnvironmentSM (LCE SM) delivers features and service attributes that offer scalability, security, flexibility and the ability to sell learning products: Scale – Amesite can meet the needs of 65k+ medium and large businesses across the U.S. eCommerce Ecosystem Solution – Customers can sell courses to Learners on a single branded, online platform that delivers proprietary, custom or third-party content. Best-in-Class Security – Customers get security and data privacy out-of-the-box. Streamlined Deployment – Customers can launch a fully branded LCESM in just 24h. Flexibility – Customers can offer courses that are branded differently, enabling different parts of an organization to deliver on their own sub-brands. Onboarding Pre-Enrollment – Learners are registered and enrolled in a simple, intuitive process that makes deployment easy. The company aims to serve the incredible need for U.S. and Global upskilling. According to Statista, the U.S. workplace training industry was valued.at approximately $165 billion in 2020. Global Market Insights expects eLearning revenue to reach $1T by 2028.Reported Earnings • May 14Third quarter 2022 earnings released: US$0.093 loss per share (vs US$0.11 loss in 3Q 2021)Third quarter 2022 results: US$0.093 loss per share (up from US$0.11 loss in 3Q 2021). Net loss: US$2.22m (loss narrowed 4.6% from 3Q 2021).공시 • Feb 15Amesite Inc. announced delayed 10-Q filingOn 02/14/2022, Amesite Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.Reported Earnings • Nov 18First quarter 2022 earnings released: US$0.11 loss per share (vs US$0.31 loss in 1Q 2021)First quarter 2022 results: Net loss: US$2.38m (loss narrowed 53% from 1Q 2021).Reported Earnings • Sep 11Full year 2021 earnings released: US$0.59 loss per shareFull year 2021 results: Net loss: US$11.6m (loss widened 178% from FY 2020).공시 • Jun 28+ 1 more updateAmesite Inc.(NasdaqCM:AMST) dropped from Russell Microcap Value IndexAmesite Inc.(NasdaqCM:AMST) dropped from Russell Microcap Value Index매출 및 비용 세부 내역Amesite가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이DB:VDE0 매출, 비용 및 순이익 (USD Millions)날짜매출순이익일반관리비연구개발비31 Mar 231-54231 Dec 221-75230 Sep 221-86330 Jun 221-97331 Mar 221-97331 Dec 211-97330 Sep 211-97330 Jun 211-126231 Mar 210-116231 Dec 200-104230 Sep 200-83230 Jun 200-43131 Mar 200-54231 Dec 190-54130 Sep 190-43130 Jun 190-43131 Mar 190-31030 Jun 180-110양질의 수익: VDE0 은(는) 현재 수익성이 없습니다.이익 마진 증가: VDE0는 현재 수익성이 없습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: VDE0은 수익성이 없으며 지난 5년 동안 손실이 연평균 20.6% 증가했습니다.성장 가속화: 현재 수익성이 없어 지난 1년간 VDE0의 수익 성장률을 5년 평균과 비교할 수 없습니다.수익 대 산업: VDE0은 수익성이 없어 지난 해 수익 성장률을 Consumer Services 업계(23.7%)와 비교하기 어렵습니다.자기자본이익률높은 ROE: VDE0는 현재 수익성이 없으므로 자본 수익률이 음수(-76.87%)입니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YConsumer-services 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2023/05/22 22:28종가2023/02/22 00:00수익2023/03/31연간 수익2022/06/30데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Amesite Inc.는 1명의 분석가가 다루고 있습니다. 이 중 명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관William SutherlandBenchmark Company
Reported Earnings • Nov 16First quarter 2023 earnings released: US$0.058 loss per share (vs US$0.11 loss in 1Q 2022)First quarter 2023 results: US$0.058 loss per share (improved from US$0.11 loss in 1Q 2022). Revenue: US$280.3k (up 99% from 1Q 2022). Net loss: US$1.58m (loss narrowed 34% from 1Q 2022). Revenue is forecast to grow 94% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Consumer Services industry in Europe.
Reported Earnings • Nov 12First quarter 2023 earnings released: US$0.058 loss per share (vs US$0.11 loss in 1Q 2022)First quarter 2023 results: US$0.058 loss per share (improved from US$0.11 loss in 1Q 2022). Revenue: US$280.3k (up 99% from 1Q 2022). Net loss: US$1.58m (loss narrowed 34% from 1Q 2022). Revenue is forecast to grow 94% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Consumer Services industry in Europe.
Reported Earnings • Sep 29Full year 2022 earnings released: US$0.39 loss per share (vs US$0.59 loss in FY 2021)Full year 2022 results: US$0.39 loss per share (improved from US$0.59 loss in FY 2021). Revenue: US$697.0k (up 3.3% from FY 2021). Net loss: US$9.06m (loss narrowed 22% from FY 2021). Revenue is forecast to grow 85% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Consumer Services industry in Europe.
Reported Earnings • May 14Third quarter 2022 earnings released: US$0.093 loss per share (vs US$0.11 loss in 3Q 2021)Third quarter 2022 results: US$0.093 loss per share (up from US$0.11 loss in 3Q 2021). Net loss: US$2.22m (loss narrowed 4.6% from 3Q 2021).
Reported Earnings • Nov 18First quarter 2022 earnings released: US$0.11 loss per share (vs US$0.31 loss in 1Q 2021)First quarter 2022 results: Net loss: US$2.38m (loss narrowed 53% from 1Q 2021).
Reported Earnings • Sep 11Full year 2021 earnings released: US$0.59 loss per shareFull year 2021 results: Net loss: US$11.6m (loss widened 178% from FY 2020).
공시 • Oct 30+ 1 more updateAmesite Inc. Announces Upcoming Product PlansAmesite announced the planned launch of what it believes is the industry’s first AI-powered EMR platform for post-acute care, aiming to deliver operational efficiency for the fastest-growing healthcare segments.
공시 • Jul 14Amesite Launches Census-Based Enterprise Tier for NurseMagic™ to Drive Revenue Growth and Meet Enterprise Demand, Significantly Expanding Total Addressable MarketAmesite Inc. announced the launch of the new NurseMagic™ Enterprise Tier, built to meet the most urgent needs of mid- and large-scale post-acute healthcare providers. Developed in direct response to customer demand, NurseMagic™ Enterprise integrates advanced, AI-powered capabilities into existing workflows — seamlessly and compliantly. By aligning pricing with patient census, Amesite believes this offering significantly increases its addressable market and supports long-term revenue growth. NurseMagic™ Enterprise includes:Seamless EMR integration. NurseMagic™ Enterprise enables bi-directional data transfer and connectivity with electronic medical records (EMRs), allowing documentation created in NurseMagic™ Enterprise to populate directly into clinical systems. This integration is designed to fit seamlessly into existing workflows — preserving continuity for staff while delivering unparalleled documentation efficiency. Automated interdisciplinary team (IDT) reporting. NurseMagic™ now generates formatted IDT reports automatically, streamlining one of the most time-intensive compliance processes for home health and hospice agencies. This feature is built to operate within current team structures — saving time without requiring teams to change how they work. Custom-formatted documentation for compliance and billing. NurseMagic™ Enterprise supports customer-specific templates for documentation required by payers, regulators, and internal teams. This assures that providers can continue to use their own established forms — now generated faster and with greater consistency with NurseMagic™’s powerful, proprietary AI tools. Census-based pricing that scales with care delivery. By tying pricing to patient census rather than staff count, NurseMagic™ enables organizations to deploy across full care teams with clarity and control. This model supports growth without operational disruption — and positions Amesite to capture revenue as census expands. With the launch of NurseMagic™ Enterprise, Amesite will discontinue new sales of its entry-level B2B Teams plan. Going forward, B2B customers will choose between Teams Plus+, intended for organizations with smaller patient censuses, and the new NurseMagic™ Enterprise Tier, which supports larger-scale deployment and full-agency efficiency. Existing Teams customers will continue to be supported. Amesite believes that consolidating around these two enhanced tiers enables the Company to capture more value from each organization served and positions it to drive stronger recurring revenue growth.
공시 • Jun 26Amesite Inc.'s HIPAA Compliant NurseMagic App Now Operates in 16 Languages - Expanding Access to AI-Powered Charting for Nearly 1 Million U.S. NursesAmesite Inc. announced that its app, NurseMagic, now supports charting in 16 languages. This major enhancement is designed to address a key barrier to success for nearly 1 million nurses in the U.S. who speak English as a second language (ESL) -- accounting for 19.2% of the nursing workforce -- and to chart more efficiently and with greater confidence. This multilingual capability positions Amesite to meet immediate market needs. Markets now able to leverage the platform include: ESL nurses in the United States: Nearly 20% of U.S. nurses have English as a Second Language (ESL); International healthcare systems treating U.S. patients: There are over 6.5 Million nurses in the top 10 medical tourist destinations for U.S. patients alone; Private clinics in multilingual regions: The private sector provides nearly 40% of all healthcare in PAHO, AFRO, and WPRO regions, 57% in SEARO, and 62% in EMRO.
공시 • May 06Amesite Announces Successful Launch of New, Higher-Priced Tier of Service in Response to B2B DemandAmesite Inc. announced the successful launch of a higher-priced enterprise tier of service of its app, NurseMagicTM. Amesite reports that businesses demanded more capacity after incorporating NurseMagicTM fully into their workflows - and have reported a strong willingness-to-pay for the increased usage at a higher price point. Amesite also reports that customers also wanted access to advanced analytics, now accessible 24/7 with the Teams Plus+ tier of service. Amesite reports a marked increase in enterprise clients deploying NurseMagic™ across entire clinical and non-clinical teams, from nurses and CNAs to chaplains, aides, and coordinators. As these customers scale usage, they gain access to real-time insights, productivity metrics, and tools that reduce costs and improve retention with the new pricing tier. This new tier follows announcements regarding meeting HIPAA regulation, delivering to the growing hospice segment and delivery of solutions for non-clinical workers in addition to clinical staff.
공시 • Apr 23Amesite Announces NurseMagic Meets HIPAA Requirements for Individuals Users, in Addition to EnterprisesAmesite Inc. announced NurseMagic now meets HIPAA requirements for all users. This extension ensures that all usage—individual or enterprise—meets regulatory standards for handling sensitive healthcare information. Amesite announced that it met HIPAA requirements for enterprises late last year, and subsequently reported increased sales in B2B. To meet HIPAA requirements, care providers are required to execute a Business Associate Agreement (BAA) with their software vendors. NurseMagic now provides a BAA for all users, whether licenses are purchased by enterprises or by individuals. Any provider can confidently enter patient details or other personally identifiable health information (PHI) into NurseMagic™’s safe, secure environment. Users can copy and paste documentation produced with NurseMagic into any electronic medical record (EMR) system, enabling them to take advantage of NurseMagic™’s AI capabilities, no matter their current software infrastructure.
공시 • Mar 11Amesite Announces Successful Soft Rollout of NurseMagic Caregiver Solution, Expanding Its Addressable Market for Enterprise by 50%Amesite Inc. announced the early adoption of its non-clinical caregiver tool in NurseMagic. The Caregiver NurseMagic Solution directly supports non-clinical workers in their day-to-day jobs, reducing the need for intensive intervention by management, and improving documentation, communication and patient care. Amesite sales are focused on home health care and skilled nursing. Agencies and corporations in these segments employ both clinical and non-clinical staff. Broadly, there are almost 3 million home health care and skilled nursing staff in the U.S., of which over 1.5 million are non-clinical healthcare support workers. By expanding NurseMagic solutions to meet the needs of non-clinical workers, Amesite estimates that it has expanded its addressable market for enterprise sales alone by around 50%. Amesite reports that an increasing number of customers have adopted NurseMagic for their entire teams, which include non-clinical staff such as CNAs, chaplains, social workers and nurse aides. Over the last three months, Amesite reported that its contracts with hospice providers have grown by over 3,000%, and contract sizes have increased by nearly 1,000%. This comes on the heels of Amesite's recent rollout of its automated purchase process that enables contract expansion with a few clicks, substantially shortening its sales cycle as it reaches the over 50,000 businesses in its target segments.
공시 • Jan 09Amesite Inc. has completed a Follow-on Equity Offering in the amount of $4.865001 million.Amesite Inc. has completed a Follow-on Equity Offering in the amount of $4.865001 million. Security Name: Common Stock Security Type: Common Stock Securities Offered: 1,201,667 Price\Range: $3 Discount Per Security: $0.24 Security Name: Common Stock Security Type: Common Stock Securities Offered: 420,000 Price\Range: $3 Discount Per Security: $0.12
공시 • Jan 07Amesite Inc. has filed a Follow-on Equity Offering.Amesite Inc. has filed a Follow-on Equity Offering. Security Name: Common Stock Security Type: Common Stock Security Name: Pre-Funded Warrants Security Type: Equity Warrant
공시 • Dec 04Amesite Receives a Deficiency Letter from the Listing Qualifications Department of the Nasdaq Stock MarketOn November 26, 2024, Amesite Inc. received a deficiency letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC notifying the Company that it is not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires the Company to maintain a minimum of $2,500,000 in stockholders’ equity for continued listing on the Nasdaq Capital Market, nor is it in compliance with either of the alternative listing standards, either a market value of listed securities of at least $35 million or net income of $500,000 from continuing operations in the most recently completed fiscal year, or in two of the three most recently completed fiscal years. Pursuant to the Nasdaq Letter, the Company has 45 calendar days from the date of the Nasdaq Letter to submit a plan to regain compliance and the Company intends to submit such a plan during this period. If it accepts the plan, Nasdaq can grant an extension of up to 180 calendar days from the date of the Nasdaq Letter to evidence compliance. In the event the plan is not accepted by Nasdaq, or in the event the plan is accepted and the 180-day extension period granted but the Company fails to regain compliance within such plan period, the Company would have the right to a hearing before an independent panel. The hearing request would stay any suspension or delisting action pending the conclusion of the hearing process and the expiration of any additional extension period granted by the panel following the hearing. The Company intends to take all reasonable measures available to regain compliance under the Nasdaq Listing Rules and remain listed on Nasdaq. However, there can be no assurance that Nasdaq will grant the Company’s request for an extension or that the Company will ultimately regain compliance with all applicable requirements for continued listing. Neither the Nasdaq Letter nor the Company’s noncompliance have an immediate effect on the listing or trading of the Company’s common shares, which will continue to trade on the Nasdaq Capital Market under the symbol “AMST”.
공시 • Nov 28Amesite Inc., Annual General Meeting, Jan 21, 2025Amesite Inc., Annual General Meeting, Jan 21, 2025.
공시 • Jul 16Amesite Inc. Launches PREACTO App in Beta to Power Safety and Security At Home, Work, School and in Public VenuesAmesite Inc. announced that the beta registration is now available for PREACTO, an innovative and proprietary app designed for personal safety and security. The new web app uses AI to provide helpful and easy-to-use tools for people who want to make their safety and security a priority, allowing them to proactively assess threats, plan safe routes and activities, update law enforcement, notify their circle of family and friends, and more. The app will also offer Active Shooter Preparedness content developed together with world renowned expert Chris Grollnek, #ActiveShooterexpert, and founder of the Active Shooter Prevention Project. Amesite and ASPP announced their collaboration in March to create the app. The app targets serving Grollnek’s expansive audience and customer base, including Fortune 100 and 500 companies, small to large corporations and businesses, the entire government sector, public entities, and other organizations. This broad client base reflects the universal need for effective crisis response training across all sectors of society. Americans are increasingly focused on reducing crime, with 58% of U.S. adults stating that crime reduction should be a top priority of the President and Congress, up from 47% in 2021. 40% of Americans, the highest percentage in three decades, report that they would be afraid to walk alone at night within a mile of their home. Fully 66% of adults reported that they avoided common activities because of fear of crime, including attending public events, visiting central areas of cities, taking walks, exercising or visiting local parks. PREACTO’s toolkit is designed to make these activities safer and more secure. RescueCall instantly notifies loved ones and emergency services, ensuring swift assistance. CrimeMap provides real-time updates on local crime activities, helping users avoid dangerous areas. The app’s SafeZone feature offers risk assessments based on a user’s current location, while SafePath provides the safest route to any destination. Additionally, WeaponSight uses phone cameras to identify potential threats, and IncidentReporter enables fast documentation and reporting of threatening behavior to law enforcement or workplace authorities.
공시 • Jul 12Amesite Inc. Announces AI-Powered Document Storage and Study Tools on NurseMagic™? App to Power Instantaneous Training for Nurses and Nursing StudentsAmesite Inc. announced that its NurseMagicTM app now supports nursing students and professionals ranging from CNAs and LPNs to APRN-CNPs and NPs. The functionality supports any type of documentation, training and learning. NurseMagicTM has experienced rapid adoption by nurses following its release to the general public, targeting over 5.2 million nurses. Its proprietary technology has demonstrated 93% accuracy when tested on prep questions for the NCLEX, the exam that must be passed by nurses in the U.S. and Canada in order to be licensed. Users can upload pdf, video and audio files to instantly create transcripts, summaries and even quizzes and flashcards based on the material. Uploadable content spans recorded and written lecture materials, training materials and professional guidelines along with informal materials created via mentorship. With the new functionality, nurses can access instantaneous training. Additionally, users can share materials easily on the app and create their own file structures, enabling scaling of distribution of informal and formal learning, training and other professional materials.
공시 • Apr 24Amesite Inc. Launches Revolutionary NurseMagic App in Beta to Empower 5.2 Million Nurses with AI ToolsAmesite Inc. announced the beta release of NurseMagic™, an innovative and proprietary app designed for nurses. This new web app uses AI to provide helpful and easy-to-use tools for over 5.2 million nurses, making their daily tasks easier and more efficient. Additionally, with its status as a Joint Provider with PACE, also offers convenient, accredited continuing education (CE) programs to nurses on the app, enabling them to meet requirements for licensure. NurseMagic™ features include: MedDecode: Quickly translates medical terms into simple language. Professional Email Generator: Creates practical work emails quickly. CareTalk: Assists nurses in talking to patients effectively and with compassion. Wellness Break: Coaches nurses on taking effective breaks during the day. MedExplainer: Enables nurses to explain medical practices to patients. Image-to-Text: Converts images to text for easy reading and communication.MedUverse: Offers key information about medications. NurseTea: Collects instant feedback through surveys that are shared with the community.
공시 • Jan 24Amesite Inc. Launches Active Shooter Preparedness Training with Expert Chris GrollnekAmesite Inc. announced the launch of its Active Shooter Preparedness Training program. This essential training is developed in collaboration with renowned active shooter prevention expert Chris Grollnek, M.S., Founder and Managing Principal of the Active Shooter Prevention Project, LLC (ASPP). Amesite's partnerships with regional and community colleges aim to deploy these learnings to a wider audience and enhance safety protocols across the country.
공시 • Jan 05Amesite Inc. Partners with Central Michigan University to Launch A Pioneering Asynchronous Implicit Bias Course for Healthcare ProfessionalsAmesite Inc. announced the launch of a new asynchronous Implicit Bias course tailored for healthcare professionals. This course is the result of a partnership between Amesite and CMU's College of Medicine, along with key insights from Dr. Sheri Pickover, a distinguished professor and program director in CMU's Counseling, Educational Leadership & Higher Education department. Delivered through CMU's Online Professional Education portal powered by Amesite's cutting-edge learning platform, this course is meticulously designed to deepen the understanding of implicit bias in healthcare settings. It goes beyond raising awareness, enabling participants to apply these vital insights in reforming healthcare policies and practices. Key Course Highlights: LARA Requirements: The asynchronous course meets the LARA two-hour training requirement as established by the State of Michigan. Medical Professionals: Earn 2.0 American Medical Association's Physician's Recognition Award Category one credits upon successful completion. Educators: Fulfill 1.0 Student Continuing Education Clock Hour (SCECH) requirements mandated by the Michigan Department of Education (MDE). This course will help foster inclusivity and reduce implicit bias within healthcare. The asynchronous course equips healthcare professionals, educators and advocates with the knowledge and tools necessary to make a tangible difference in their respective fields.
공시 • Dec 09Amesite Inc., Annual General Meeting, Jan 18, 2024Amesite Inc., Annual General Meeting, Jan 18, 2024, at 08:45 US Eastern Standard Time. Agenda: To consider the election of three Class III Directors to hold office until successors are duly elected and qualified or until the 2026 Annual Meeting of Stockholders; to consider the ratification of the appointment of Turner, Stone & Company, L.L.P. as the Company's independent registered public accounting firm for the fiscal year ending June 30, 2024; and to transact such other matters as may properly come before the Annual Meeting and any adjournment or postponement thereof.
공시 • Sep 28Amesite Inc. announced delayed annual 10-K filingOn 09/27/2023, Amesite Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
공시 • Jun 29Amesite Announces V6.3, with Streamlined, AI-First Infrastructure to Enable Customization and Scale for Its Enterprise CustomersAmesite Inc. announces that V6.3 will be available to its Customers on July 10, 2023. By implementing Azure's cloud solutions, Amesite has enhanced its platform’s efficiency and ensured secure authentication with Azure AD B2C. The incorporation of Azure's latest database technology enables Amesite to deliver services faster and improve user experiences. The centralization of Amesite’s innovation deployments allows rapid access to new features such as games and other AI offerings. This significant update reaffirms Amesite’s dedication to addressing customers' ever-evolving needs and delivering an unrivaled user experience. Amesite’s V6.3 includes upgraded cybersecurity with centralized security measures and updates to fortify protection against cyber threats. Enhanced visibility achieved through centralized monitoring allows proactive identification of vulnerabilities, paired with the ability to rapidly deploy security patches across all tenants. In addition, Amesite’s scalable customer support facilitates frictionless resource allocation to manage Customer inquiries and onboarding efficiently.
공시 • Feb 15+ 1 more updateAmesite Inc. announced delayed 10-Q filingOn 02/14/2023, Amesite Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Dec 17Amesite Inc. Announces CFO ChangesOn December 9, 2022, the board of directors of Amesite Inc. authorized and approved the appointment of Sherlyn W. Farrell, age 60, as Chief Financial Officer of the Company effective December 15, 2022. In connection with Ms. Farrell’s appointment, the Board determined not to renew the engagement of Mark Corrao, who previously served as the Company’s Chief Financial Officer since December 15, 2021 for a term of one year in accordance with the CFO Agreement between the Company and Mr. Corrao. Ms. Farrell has extensive experience in accounting, financial analysis, and risk management. Since 2005, Ms. Farrell has served as President of Seven Kites Strategic Consulting Inc. (“Seven Kites”), where she focused on strategic planning, CFO oversight, financial reporting and analysis. Prior to Seven Kites, Ms. Farrell served as Chief Executive Officer of RGL Forensics from 2000 through 2005. RGL Forensics was a leading financial investigations company that specialized in the insurance, legal and corporate markets that was acquired by Baker Tilly in 2018. From 1999 – 2000, Ms. Farrell served as a Partner /Senior Consultant at RiskCap where she focused on the alternative risk finance arena developing and managing specialty insurance programs, including medical malpractice, workers compensation, general liability and warranty programs. Prior to RiskCap, Ms. Farrell was an audit manager at KPMG from 1984 – 1989.
Reported Earnings • Nov 16First quarter 2023 earnings released: US$0.058 loss per share (vs US$0.11 loss in 1Q 2022)First quarter 2023 results: US$0.058 loss per share (improved from US$0.11 loss in 1Q 2022). Revenue: US$280.3k (up 99% from 1Q 2022). Net loss: US$1.58m (loss narrowed 34% from 1Q 2022). Revenue is forecast to grow 94% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Consumer Services industry in Europe.
Reported Earnings • Nov 12First quarter 2023 earnings released: US$0.058 loss per share (vs US$0.11 loss in 1Q 2022)First quarter 2023 results: US$0.058 loss per share (improved from US$0.11 loss in 1Q 2022). Revenue: US$280.3k (up 99% from 1Q 2022). Net loss: US$1.58m (loss narrowed 34% from 1Q 2022). Revenue is forecast to grow 94% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Consumer Services industry in Europe.
공시 • Oct 29Amesite Inc., Annual General Meeting, Dec 15, 2022Amesite Inc., Annual General Meeting, Dec 15, 2022, at 08:45 US Eastern Standard Time. Agenda: To consider Election of two Class II Directors to hold office until successors are duly elected and qualified or until the 2025 Annual Meeting of Stockholders; to Ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending June 30, 2023; and to consider other business matters.
Reported Earnings • Sep 29Full year 2022 earnings released: US$0.39 loss per share (vs US$0.59 loss in FY 2021)Full year 2022 results: US$0.39 loss per share (improved from US$0.59 loss in FY 2021). Revenue: US$697.0k (up 3.3% from FY 2021). Net loss: US$9.06m (loss narrowed 22% from FY 2021). Revenue is forecast to grow 85% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Consumer Services industry in Europe.
공시 • Jun 23Amesite Inc. Announces Expansion of Its Capabilities to Serve Larger Entities, with the Launch of Version 5.0 of Its AI-Driven Online Learning PlatformAmesite Inc. announced the expansion of its capabilities to serve larger entities, with the launch of Version 5.0 of its AI-driven online learning platform. Version 5.0 of the Amesite Learning Community EnvironmentSM (LCE SM) delivers features and service attributes that offer scalability, security, flexibility and the ability to sell learning products: Scale – Amesite can meet the needs of 65k+ medium and large businesses across the U.S. eCommerce Ecosystem Solution – Customers can sell courses to Learners on a single branded, online platform that delivers proprietary, custom or third-party content. Best-in-Class Security – Customers get security and data privacy out-of-the-box. Streamlined Deployment – Customers can launch a fully branded LCESM in just 24h. Flexibility – Customers can offer courses that are branded differently, enabling different parts of an organization to deliver on their own sub-brands. Onboarding Pre-Enrollment – Learners are registered and enrolled in a simple, intuitive process that makes deployment easy. The company aims to serve the incredible need for U.S. and Global upskilling. According to Statista, the U.S. workplace training industry was valued.at approximately $165 billion in 2020. Global Market Insights expects eLearning revenue to reach $1T by 2028.
Reported Earnings • May 14Third quarter 2022 earnings released: US$0.093 loss per share (vs US$0.11 loss in 3Q 2021)Third quarter 2022 results: US$0.093 loss per share (up from US$0.11 loss in 3Q 2021). Net loss: US$2.22m (loss narrowed 4.6% from 3Q 2021).
공시 • Feb 15Amesite Inc. announced delayed 10-Q filingOn 02/14/2022, Amesite Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
Reported Earnings • Nov 18First quarter 2022 earnings released: US$0.11 loss per share (vs US$0.31 loss in 1Q 2021)First quarter 2022 results: Net loss: US$2.38m (loss narrowed 53% from 1Q 2021).
Reported Earnings • Sep 11Full year 2021 earnings released: US$0.59 loss per shareFull year 2021 results: Net loss: US$11.6m (loss widened 178% from FY 2020).
공시 • Jun 28+ 1 more updateAmesite Inc.(NasdaqCM:AMST) dropped from Russell Microcap Value IndexAmesite Inc.(NasdaqCM:AMST) dropped from Russell Microcap Value Index